Save your place

Sign in to WhoBought

Please try again later.

Eledon Pharmaceuticals, Inc. (ELDN) institutional ownership

Latest close $3.86 Jul 20, 2026
Market cap$202M 52-week range SectorHealthcare
Funds holding · Q1 2026
109
reported ELDN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
74 buyers · 35 sellers

Eledon Pharmaceuticals, Inc. (ELDN) price and institutional activity

Dates

Q1 2026

$0 bought by 74 investors
Bank of America CorpBlackRock +72 more
$0 sold by 35 investors
Stonepine Capital Management, LLCAdar1 Capital Management, LLC +33 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Eledon Pharmaceuticals, Inc. (ELDN) institutional activity · 109

Investor Type Est. change Change Δ Own Date
Stonepine Capital Management, LLC · Reduced
Change −858K Date Q1 2026
Stonepine Capital Management, LLC Reduced· Q1 2026 −858K Q1 2026
Adar1 Capital Management, LLC · Reduced
Change −847K Date Q1 2026
Adar1 Capital Management, LLC Reduced· Q1 2026 −847K Q1 2026
Bank of America Corp · Added
Change +809K Date Q1 2026
Bank of America Corp Added· Q1 2026 +809K Q1 2026
BlackRock · Added
Change +755K Date Q1 2026
BlackRock Added· Q1 2026 +755K Q1 2026
Caligan Partners LP · Exited
Change −556K Δ Own −100.0% Date Q1 2026
Caligan Partners LP Exited· Q1 2026 −556K −100.0% Q1 2026
Blue Owl Capital Holdings LP · Reduced
Change −510K Date Q1 2026
Blue Owl Capital Holdings LP Reduced· Q1 2026 −510K Q1 2026
Zimmer Partners, LP · Reduced
Change −509K Date Q1 2026
Zimmer Partners, LP Reduced· Q1 2026 −509K Q1 2026
Jane Street Group, LLC · Exited
Change −489K Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −489K −100.0% Q1 2026
Jefferies Financial Group Inc. · Reduced
Change −486K Date Q1 2026
Jefferies Financial Group Inc. Reduced· Q1 2026 −486K Q1 2026
State Street · Added
Change +381K Date Q1 2026
State Street Added· Q1 2026 +381K Q1 2026
Catalio Capital Management, LP · Added
Change +380K Date Q1 2026
Catalio Capital Management, LP Added· Q1 2026 +380K Q1 2026
Geode · Added
Change +370K Date Q1 2026
Geode Added· Q1 2026 +370K Q1 2026
Sphera Funds Management Ltd. · Reduced
Change −360K Date Q1 2026
Sphera Funds Management Ltd. Reduced· Q1 2026 −360K Q1 2026
Focus Partners Wealth · Exited
Change −317K Δ Own −100.0% Date Q1 2026
Focus Partners Wealth Exited· Q1 2026 −317K −100.0% Q1 2026
Defilade Capital Management, L.P. · Added
Change +274K Date Q1 2026
Defilade Capital Management, L.P. Added· Q1 2026 +274K Q1 2026
Data through Q1 2026 · filed May 21, 2026
15 of 109

Famous investor activity in Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals, Inc. (ELDN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
McBride John S. · Director 2 operations 0
Owned 0 Trade date Jan 10, 2026 Filed date Jan 16, 2026
McBride John S. Director 2 operations 0 0 Jan 10, 2026 Jan 16, 2026
Hillson Jan · Director 2 operations 0
Owned 0 Trade date Jan 10, 2026 Filed date Jan 16, 2026
Hillson Jan Director 2 operations 0 0 Jan 10, 2026 Jan 16, 2026
Kirk Allan · Director 2 operations 0
Owned 0 Trade date Jan 10, 2026 Filed date Jan 16, 2026
Kirk Allan Director 2 operations 0 0 Jan 10, 2026 Jan 16, 2026
Katkin Keith · Director 2 operations 0
Owned 0 Trade date Jan 10, 2026 Filed date Jan 16, 2026
Katkin Keith Director 2 operations 0 0 Jan 10, 2026 Jan 16, 2026
Lee June · Director 2 operations 0
Owned 0 Trade date Jan 10, 2026 Filed date Jan 16, 2026
Lee June Director 2 operations 0 0 Jan 10, 2026 Jan 16, 2026
Robinson James A. Jr · Director 2 operations 0
Owned 0 Trade date Jan 10, 2026 Filed date Jan 16, 2026
Robinson James A. Jr Director 2 operations 0 0 Jan 10, 2026 Jan 16, 2026
6 of 6

Eledon Pharmaceuticals, Inc. (ELDN) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Biotechnology Value Fund L P 5.4M
% of shares outstanding 6.8% Filing date May 15, 2026
Biotechnology Value Fund L P 5.4M 6.8% May 15, 2026
Armistice Capital, LLC
% of shares outstanding 6.0% Filing date Nov 14, 2024
Armistice Capital, LLC 6.0% Nov 14, 2024
Blackrock, Inc. 4.4M
% of shares outstanding 5.8% Filing date Apr 27, 2026
Blackrock, Inc. 4.4M 5.8% Apr 27, 2026
Coastlands Capital LP 3.9M
% of shares outstanding 5.0% Filing date Feb 13, 2026
Coastlands Capital LP 3.9M 5.0% Feb 13, 2026
Frazier Life Sciences Public Fund, L.P. 2.7M
% of shares outstanding 4.6% Filing date Nov 5, 2024
Frazier Life Sciences Public Fund, L.P. 2.7M 4.6% Nov 5, 2024
The Vanguard Group 0
% of shares outstanding 0.0% Filing date Mar 26, 2026
The Vanguard Group 0 0.0% Mar 26, 2026
Ra Capital Management, L.P. 0
% of shares outstanding 0.0% Filing date Feb 17, 2026
Ra Capital Management, L.P. 0 0.0% Feb 17, 2026
7 of 7

Eledon Pharmaceuticals, Inc. (ELDN) ownership FAQ

Who owns ELDN?

109 reporting institutions disclosed ELDN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.